PACS GroupPACS +3.96%19 EBITDA Margin % is 9.73% as of Mar. 2026, which is 30% above its 10-year median of 7.48. GuruFocus rates PACS with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PACS Group ranks worse than 55.99% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. PACS Group's EBITDA for the
three
months ended in Mar. 2026 was $138 Mil. PACS Group's Revenue for the
three
months ended in Mar. 2026 was $1,420 Mil. Therefore, PACS Group's EBITDA margin for the quarter that ended in Mar. 2026 was 9.73%.
PACS Group (NYSE:PACS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PACS Group EBITDA Margin % Related Terms
PACS Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for PACS Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PACS vs CHE, OPCH, CON: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, PACS Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PACS Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PACS Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PACS Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PACS Group (PACS) has a EBITDA Margin % of 9.73% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PACS Group and its competitors. This is 30% above median its historical median of 7.48. Over the past decade, PACS Group's EBITDA Margin % has ranged from 4.57 to 10.52. According to the industry distribution chart, PACS Group ranks #374 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 56%.
Is PACS Group's EBITDA Margin % too high?
PACS Group's current EBITDA Margin % of 9.73% is 30% above median its 10-year median of 7.48. Over the past 10 years, this metric has ranged from a low of 4.57 to a high of 10.52. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. PACS Group's value of 9.73% is 4.7% below this industry median. Based on the distribution chart, PACS Group ranks #374 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PACS Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PACS Group's EBITDA Margin % compare to CHE and OPCH?
According to the Healthcare Providers & Services industry distribution chart, PACS Group ranks #374 out of 668 companies for EBITDA Margin %. This places PACS Group in the lower half of its industry. The industry median EBITDA Margin % is 10.21. PACS Group's value of 9.73% is 4.7% below this benchmark. Historically, PACS Group's own EBITDA Margin % has ranged from 4.57 to 10.52 over the past decade. While the company's 10-year median is 7.48 vs. the industry median of 10.21, PACS Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PACS Group's current EBITDA Margin % of 9.73% is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PACS Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PACS Group's current EBITDA Margin % is 9.73%, which is 30% above median its own 10-year median of 7.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PACS Group stock overvalued right now?
PACS Group (PACS) has a current EBITDA Margin % of 9.73%. The current EBITDA Margin % is 9.73%, which is 30% above median its 10-year median of 7.48 and 4.7% below the Healthcare Providers & Services industry median of 10.21. PACS Group's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PACS Group (PACS), the current EBITDA Margin % is 9.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
19GF Score
Get the complete analysis for PACS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACS has been successfully added to your 
